These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27832037)

  • 21. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Zhang MM; Qian W; Qin YY; He J; Zhou YH
    World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic consequences of Helicobacter pylori infection and eradication.
    Buzás GM
    World J Gastroenterol; 2014 May; 20(18):5226-34. PubMed ID: 24833852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
    Yoon H; Lee DH; Kim N; Park YS; Shin CM; Kang KK; Oh DH; Jang DK; Chung JW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1801-9. PubMed ID: 24118110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes.
    Huang B; Yan S; Chen C; Ye S
    Wien Klin Wochenschr; 2019 Feb; 131(3-4):75-80. PubMed ID: 30542778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta-analysis.
    Kale-Pradhan PB; Mihaescu A; Wilhelm SM
    Pharmacotherapy; 2015 Aug; 35(8):719-30. PubMed ID: 26173786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
    Basyigit S; Kefeli A; Sapmaz F; Yeniova AO; Asilturk Z; Hokkaomeroglu M; Uzman M; Nazligul Y
    Bosn J Basic Med Sci; 2015 Oct; 15(4):50-4. PubMed ID: 26614852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
    Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
    Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Helicobacter pylori eradication on blood ammonia levels in cirrhotic patients: a systematic review.
    Qin SY; Jiang HX; Ning HJ; Nie HM; Tao L; Hu BL; Guo XY
    Hepatogastroenterology; 2012; 59(120):2576-81. PubMed ID: 22591680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
    Ozaki H; Harada S; Takeuchi T; Kawaguchi S; Takahashi Y; Kojima Y; Ota K; Hongo Y; Ashida K; Sakaguchi M; Tokioka S; Sakamoto H; Furuta T; Tominaga K; Higuchi K
    Digestion; 2018; 97(3):212-218. PubMed ID: 29393194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Song ZQ; Zhou LY
    World J Gastroenterol; 2016 May; 22(19):4766-75. PubMed ID: 27217708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy.
    Zhu R; Chen K; Zheng YY; Zhang HW; Wang JS; Xia YJ; Dai WQ; Wang F; Shen M; Cheng P; Zhang Y; Wang CF; Yang J; Li JJ; Lu J; Zhou YQ; Guo CY
    World J Gastroenterol; 2014 Dec; 20(47):18013-21. PubMed ID: 25548501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta-analysis.
    Song X; Cai C; Jin Q; Chen X; Yu C
    Helicobacter; 2021 Apr; 26(2):e12781. PubMed ID: 33465265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
    Wu JY; Hsu PI; Wu DC; Graham DY; Wang WM
    Helicobacter; 2014 Jun; 19(3):207-13. PubMed ID: 24612093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Ye CL; Liao GP; He S; Pan YN; Kang YB; Zhang ZY
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):443-55. PubMed ID: 24677603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.